How should we fund the development of drugs to treat resistant diseases?

This article proposes that governments fund them to do the development, and later are entitled to the drug at a reasonable price. That could be good if all governments will be entitled to the drug at a reasonable price. But I suspect that all but the sponsoring country will have to pay through the nose.

Inviting Big Pharma companies in will surely mean letting them gouge. They will find an excuse, or simply insist.

I think that the drug-manufacturing know-how should be available to any country that either (1) is poor or (2) sponsors drug research appropriately for the size of its economy.

*EU leaders urge unfettered probe into origins of COVID-19.*

I too think that is called for. To achieve it calls for not giving presenting the possibility of a lab leak as wrongdoing by China. It would be a mistake.

*Whistleblower Craig Murray Sentenced To 8 Months In Prison Over His Reporting On Former Scottish First Minister's Trial.*

The G7's agreement on a global tax system for multinational companies will mostly increase tax revenue for their home countries. It won't do much good for poor countries they operate in.

One Indian village is praying to a new goddess, "Mother Corona", to stop the disease.

That's where religion comes from.